Latest News
Lorus Therapeutics Inc. completes private placement of 20,625,000 units
11 June 2012 - Lorus Therapeutics Inc. (TSX:LOR), a clinical stage cancer drug development company, has announced today that it has completed its earlier announced private placement of 20,625,000 units.

The units are priced at a subscription price of USD0.32 per unit. Each unit includes one common share and one common share purchase warrant.

The company has generated gross proceeds of USD6,600,000 from the private placement.

Login
Username:

Password: